Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Martin L. Biniossek et al.|Cell Communication and Signaling|2023Cited by 12
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Nathan A. Lack, Umut Berkay Altıntaş et al.|Communications Biology|2025Cited by 6
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ezgi Yağmur Kala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0